Sio Gene Therapies Inc (SIOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,505 | -11,486 | -8,406 | -71,887 | -58,563 |
| Depreciation Amortization | 137 | 137 | 271 | 666 | 187 |
| Accounts payable and accrued liabilities | -3,783 | -2,021 | -1,744 | 2,643 | 5,270 |
| Other Working Capital | -6,902 | -5,765 | -382 | 3,443 | 5,599 |
| Other Operating Activity | 7,367 | 5,371 | 1,580 | 4,789 | 4,983 |
| Operating Cash Flow | $-18,686 | $-13,764 | $-8,681 | $-60,346 | $-42,524 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -100 | -100 | -277 | -695 | -336 |
| Sale Of Investment | N/A | N/A | N/A | 4,343 | 4,343 |
| Investing Cash Flow | $-100 | $-100 | $-277 | $3,648 | $4,007 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 1,441 | 1,441 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $1,441 | $1,441 |
| Beginning Cash Position | 64,913 | 64,913 | 64,913 | 120,170 | 120,170 |
| End Cash Position | 46,127 | 51,049 | 55,955 | 64,913 | 83,094 |
| Net Cash Flow | $-18,786 | $-13,864 | $-8,958 | $-55,257 | $-37,076 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,686 | -13,764 | -8,681 | -60,346 | -42,524 |
| Capital Expenditure | -290 | -290 | -277 | -695 | -336 |
| Free Cash Flow | -18,976 | -14,054 | -8,958 | -61,041 | -42,860 |